Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

147.63 -1.05 (-0.70%)
Streaming Delayed Price Updated: 3:17 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Insulet Reports First Quarter 2026 Results
From Insulet Corporation
Via Business Wire
News headline image
Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities
From Insulet Corporation
Via Business Wire
News headline image
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Participate in BofA Securities 2026 Health Care Conference
From Insulet Corporation
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026
From Insulet Corporation
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
Insulet Appoints Mike Panos as Chief Commercial Officer
From Insulet Corporation
Via Business Wire
News headline image
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.
From Insulet Corporation, Inc.
Via Business Wire
News headline image
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
From Insulet Corporation
Via Business Wire
News headline image
Insulet Reports Fourth Quarter and Full Year 2025 Results
From Insulet Corporation
Via Business Wire
News headline image
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
From Insulet Corporation
Via Business Wire
News headline image
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
From Insulet Corporation
Via Business Wire
News headline image
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
From Insulet Corporation
Via Business Wire
News headline image
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
From Insulet Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>